Fincher Timothy R, O'Brien John C, McCarty Todd M, Fisher Tammy L, Preskitt John T, Lieberman Zelig H, Stephens Jeffrey F, Kuhn Joseph A
Department of Surgery, Baylor University Medical Center, Dallas, TX, USA.
Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):844-8. doi: 10.1001/archotol.130.7.844.
To analyze lymphatic drainage patterns and recurrence patterns in patients undergoing sentinel lymph node biopsy (SLNB) for cutaneous head and neck melanoma.
Retrospective review of a consecutive series with a mean follow-up of 35 months.
Tertiary cancer care center.
Fifty-one patients with clinically node-negative cutaneous melanoma of the head and neck region staged by means of SLNB.
Sentinel lymph nodes (SLNs) were identified using preoperative lymphatic mapping along with intraoperative gamma probe evaluation and isosulfan blue dye injection. Patients with a positive SLNB finding by hematoxylin-eosin or immunohistochemical evaluation underwent completion lymphadenectomy of the affected lymphatic basin and were considered for further adjuvant treatment. Patients with a negative SLNB finding were observed clinically.
Location characteristics of SLNs, incidence of positive SLNs, same-basin recurrence, and disease-free survival.
The mean number of SLNs per patients was 2.75. The extent of SLNB included removal of 1 node (n = 11), multiple nodes from 1 basin (n = 18), 1 node in multiple basins (n = 7), and multiple nodes in multiple basins (n = 15). Drainage to unexpected basins was found in 13 of 51 patients. Parotid region drainage was identified in 18 patients. There were no same-basin recurrences in patients with a negative SLNB finding. Thirty-six-month disease-free survival was 88.9% for patients with a negative SLN and 72.9% for patients with a positive SLN (P=.17).
The number and location of SLNs is variable and difficult to predict for head and neck cutaneous melanoma. Preoperative lymphoscintigraphy is an important planning instrument to guide complete removal of all SLNs. Based on 3-year follow-up, this procedure can be expected to provide low same-basin recurrence rates for patients with a negative SLN.
分析接受前哨淋巴结活检(SLNB)的头颈部皮肤黑色素瘤患者的淋巴引流模式和复发模式。
对连续系列病例进行回顾性分析,平均随访35个月。
三级癌症护理中心。
51例通过SLNB分期的头颈部临床淋巴结阴性皮肤黑色素瘤患者。
术前通过淋巴造影定位前哨淋巴结(SLN),术中使用γ探针评估并注射异硫蓝染料。苏木精-伊红或免疫组化评估显示SLNB结果为阳性的患者接受受累淋巴区域的根治性淋巴结清扫术,并考虑进一步的辅助治疗。SLNB结果为阴性的患者进行临床观察。
SLN的位置特征、SLN阳性发生率、同一区域复发率和无病生存率。
每位患者SLN的平均数量为2.75个。SLNB的范围包括切除1个淋巴结(n = 11)、从1个区域切除多个淋巴结(n = 18)、在多个区域切除1个淋巴结(n = 7)以及在多个区域切除多个淋巴结(n = 15)。51例患者中有13例出现引流至意外区域的情况。18例患者发现有腮腺区域引流。SLNB结果为阴性的患者未出现同一区域复发。SLN阴性患者的36个月无病生存率为88.9%,SLN阳性患者为72.9%(P = 0.17)。
头颈部皮肤黑色素瘤的SLN数量和位置各不相同且难以预测。术前淋巴闪烁显像术是指导完整切除所有SLN的重要规划工具。基于3年的随访,预计该手术可使SLN阴性患者的同一区域复发率较低。